Stock Pick by Dan Bart

DNDN: Fight against cancer

Start trading DNDN with real money!

Rate Analysis

3 ratings

Posted 581 days ago on 4/19/08

Market call:DNDN will go UP
Target: $7.00 on 10/19/08
Current: $28.01 (374.75% from time of market call)

Dendreon Corporation is developing new ways and medicines against prostate cancer and other forms of cancer. With these new and effective medicines, the stock will no doubt increase. DNDN is supposedly working on a breakthrough drug to combat cancer, if this drug is approved, expect the stock to improve.

Add a Comment

Comments

Sort: Date Posted | Member

No results found

Subscribe to Stock Analyses Comments feed: